IQuest Enterprises, a multi-sector investment company, on Monday said it has entered into a definitive agreement to acquire the API (active pharmaceutical ingredient) operations of global pharmaceutical major Viatris in India. A press release from IQuest said it emerged as the preferred investor following a global competitive bid.
from IndiaTV Business: Google News Feed https://ift.tt/9uFKpnw
0 Comments